Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient

Euglycemic diabetic ketoacidosis (euDKA) is a rare but deadly complication of sodium-glucose cotransport-2 (SGLT-2) inhibitors. Primarily indicated for the treatment of Type 2 Diabetes Mellitus, the incidence of euDKA is expected to rise as SGLT-2 inhibitors become a mainstay therapy for diabetics w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathore, Azeem, Gupta, Nidhi, Kahn, Cameron, Kadariya, Dinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: UMF “Gr. T. Popa” Iasi Publishing House 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258732/
https://www.ncbi.nlm.nih.gov/pubmed/37313125
http://dx.doi.org/10.22551/2023.39.1002.10248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258732/
https://www.ncbi.nlm.nih.gov/pubmed/37313125
http://dx.doi.org/10.22551/2023.39.1002.10248

Ejemplares similares